Logo image of BSTZ

BLACKROCK SCI & TECH TRM TR (BSTZ) Stock Overview

USA - NYSE:BSTZ - US09260K1016

22.24 USD
+0.04 (+0.18%)
Last: 9/19/2025, 8:04:01 PM
22.24 USD
0 (0%)
After Hours: 9/19/2025, 8:04:01 PM
Fundamental Rating

3

Taking everything into account, BSTZ scores 3 out of 10 in our fundamental rating. BSTZ was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BSTZ have multiple concerns. BSTZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BSTZ was profitable.
In the past year BSTZ had a positive cash flow from operations.
Of the past 5 years BSTZ 4 years were profitable.
BSTZ had a positive operating cash flow in each of the past 5 years.
BSTZ Yearly Net Income VS EBIT VS OCF VS FCFBSTZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

Industry RankSector Rank
ROA 16.3%
ROE 16.55%
ROIC 8.26%
ROA(3y)-17.73%
ROA(5y)0.59%
ROE(3y)-17.95%
ROE(5y)0.68%
ROIC(3y)N/A
ROIC(5y)N/A
BSTZ Yearly ROA, ROE, ROICBSTZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

BSTZ's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of BSTZ has declined.
In the last couple of years the Gross Margin of BSTZ has declined.
Industry RankSector Rank
OM 88.06%
PM (TTM) 137.81%
GM 88.56%
OM growth 3Y0.3%
OM growth 5Y-8.94%
PM growth 3Y20.98%
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y-8.53%
BSTZ Yearly Profit, Operating, Gross MarginsBSTZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, BSTZ has less shares outstanding
The number of shares outstanding for BSTZ has been reduced compared to 5 years ago.
The debt/assets ratio for BSTZ is higher compared to a year ago.
BSTZ Yearly Shares OutstandingBSTZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
BSTZ Yearly Total Debt VS Total AssetsBSTZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BSTZ has an Altman-Z score of 37.68. This indicates that BSTZ is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of BSTZ is 0.03, which is an excellent value as it means it would take BSTZ, only 0.03 years of fcf income to pay off all of its debts.
BSTZ has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Although BSTZ does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 37.68
ROIC/WACCN/A
WACCN/A
BSTZ Yearly LT Debt VS Equity VS FCFBSTZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

2.3 Liquidity

BSTZ has a Current Ratio of 0.02. This is a bad value and indicates that BSTZ is not financially healthy enough and could expect problems in meeting its short term obligations.
BSTZ has a Quick Ratio of 0.02. This is a bad value and indicates that BSTZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
BSTZ Yearly Current Assets VS Current LiabilitesBSTZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.10% over the past year.
BSTZ shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.63% yearly.
BSTZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 2444.93%.
The Revenue for BSTZ have been decreasing by -14.19% on average. This is quite bad
EPS 1Y (TTM)4.1%
EPS 3Y6.9%
EPS 5Y21.63%
EPS Q2Q%148.53%
Revenue 1Y (TTM)2444.93%
Revenue growth 3Y-14.19%
Revenue growth 5YN/A
Sales Q2Q%482.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BSTZ Yearly Revenue VS EstimatesBSTZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

BSTZ is valuated cheaply with a Price/Earnings ratio of 5.84.
When comparing the Price/Earnings ratio of BSTZ to the average of the S&P500 Index (27.38), we can say BSTZ is valued rather cheaply.
Industry RankSector Rank
PE 5.84
Fwd PE N/A
BSTZ Price Earnings VS Forward Price EarningsBSTZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.59
EV/EBITDA N/A
BSTZ Per share dataBSTZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.27
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

BSTZ has a Yearly Dividend Yield of 10.59%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.38, BSTZ pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.59%

5.2 History

BSTZ has been paying a dividend for over 5 years, so it has already some track record.
BSTZ has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
BSTZ Yearly Dividends per shareBSTZ Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

BSTZ pays out 54.87% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP54.87%
EPS Next 2YN/A
EPS Next 3YN/A
BSTZ Yearly Income VS Free CF VS DividendBSTZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B
BSTZ Dividend Payout.BSTZ Dividend Payout, showing the Payout Ratio.BSTZ Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK SCI & TECH TRM TR

NYSE:BSTZ (9/19/2025, 8:04:01 PM)

After market: 22.24 0 (0%)

22.24

+0.04 (+0.18%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)09-04 2025-09-04
Earnings (Next)03-05 2026-03-05
Inst Owners28.17%
Inst Owner Change-7.68%
Ins Owners0.17%
Ins Owner Change0%
Market Cap1.53B
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield 10.59%
Yearly Dividend2.05
Dividend Growth(5Y)N/A
DP54.87%
Div Incr Years1
Div Non Decr Years1
Ex-Date10-15 2025-10-15 (0.1625)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.84
Fwd PE N/A
P/S 7.61
P/FCF 6.59
P/OCF 6.59
P/B 0.91
P/tB 0.91
EV/EBITDA N/A
EPS(TTM)3.81
EY17.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.38
FCFY15.18%
OCF(TTM)3.38
OCFY15.18%
SpS2.92
BVpS24.35
TBVpS24.35
PEG (NY)N/A
PEG (5Y)0.27
Profitability
Industry RankSector Rank
ROA 16.3%
ROE 16.55%
ROCE 10.46%
ROIC 8.26%
ROICexc 8.26%
ROICexgc 8.26%
OM 88.06%
PM (TTM) 137.81%
GM 88.56%
FCFM 115.42%
ROA(3y)-17.73%
ROA(5y)0.59%
ROE(3y)-17.95%
ROE(5y)0.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y4.88%
ROICexcg growth 5YN/A
ROICexc growth 3Y4.97%
ROICexc growth 5YN/A
OM growth 3Y0.3%
OM growth 5Y-8.94%
PM growth 3Y20.98%
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y-8.53%
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 8850
Cash Conversion N/A
Profit Quality 83.75%
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 37.68
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.1%
EPS 3Y6.9%
EPS 5Y21.63%
EPS Q2Q%148.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2444.93%
Revenue growth 3Y-14.19%
Revenue growth 5YN/A
Sales Q2Q%482.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y686.05%
EBIT growth 3Y-13.93%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.1%
FCF growth 3Y2.74%
FCF growth 5YN/A
OCF growth 1Y34.1%
OCF growth 3Y2.74%
OCF growth 5YN/A